deoxyglucose has been researched along with Pancreatic Neoplasms in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (10.91) | 18.7374 |
1990's | 25 (45.45) | 18.2507 |
2000's | 7 (12.73) | 29.6817 |
2010's | 13 (23.64) | 24.3611 |
2020's | 4 (7.27) | 2.80 |
Authors | Studies |
---|---|
Joo, SS; Kim, HS; Yoo, YM | 1 |
Bai, J; Chen, J; Gao, C; Li, H; Meng, Z; Shen, Q; Wu, H; Wu, S; Yin, T; Zhang, H | 1 |
Chen, Q; Dai, S; Hou, C; Liu, T; Miao, Y; Peng, Y; Wu, J; Xu, D; Xu, W; Zhu, F; Zhu, X; Zhu, Y | 1 |
Ishibashi, Y; Ogawa, T; Ohshika, S; Ono, K; Sasaki, A; Yamada, K | 1 |
Azuma, T; Goto, A; Hidaka, A; Hirata, Y; Inoue, M; Iwasaki, M; Kobayashi, T; Nakagawa, T; Nishiumi, S; Sawada, N; Shimazu, T; Tsugane, S; Yamaji, T; Yamanaka, K; Yoshida, M | 1 |
Fujii, T; Ishino, K; Kawahara, K; Kawamoto, Y; Kitamura, T; Kudo, M; Kure, S; Naito, Z; Peng, WX; Teduka, K; Wada, R; Yamamoto, T | 1 |
Chen, C; Fei, K; Guo, L; Ju, R; Li, J; Li, S; Ye, C; Zhang, D; Zhu, L | 1 |
Bruno, S; Butera, G; Conti, P; Donadelli, M; Margiotta, M; Mullappilly, N; Pacchiana, R; Riganti, C | 1 |
Cheng, Y; Dang, CX; Diao, DM; Song, YC; Zhang, H | 1 |
Beasley, TM; Boothman, DA; Buchsbaum, DJ; Kim, H; Lee, SK; Li, LS; Martin, A; Rigell, CJ; Samuel, SL; Stockard, CR; Umphrey, HR; Zhai, G; Zinn, KR | 1 |
Gao, N; Kurtoglu, M; Lampidis, TJ; Lehrman, MA; Leung, HJ; Liu, H; Murray, TG; Philips, KB | 1 |
Cheng, G; Dwinell, MB; Kalyanaraman, B; McAllister, D; Tsai, S; Zielonka, J | 1 |
Baker, AF; Carbajal, L; Gill, A; Hanke, NT; Malm, SW | 1 |
Nagatomo, K; Ono, K; Otsuka, Y; Sasaki, A; Teshima, T; Yamada, K; Yamamoto, T | 1 |
Anderson, KM; Guinan, P; Jajeh, J; Rubenstein, M | 1 |
Kurtoglu, M; Lampidis, TJ; Liu, H; Liu, X; Savaraj, N; Wangpaichitr, M; Xi, H; You, M | 1 |
Goldberg, L; Israeli, R; Kloog, Y | 1 |
Li, S; Liu, T; Wang, F; Xiao, H; Yu, M; Zhang, D | 1 |
Russell, ST; Tisdale, MJ | 1 |
Asaka, M; Chen, J; Higashino, F; Hosokawa, M; Katoh, H; Kobayashi, M; Kuge, Y; Nakada, K; Okada, F; Shindo, M; Sugiyama, T; Takeda, K; Tamaki, N; Wang, J; Zhao, S | 1 |
Ichiyanagi, K; Inoue, T; Ogata, N; Sakai, T; Yamanouchi, T | 1 |
Lampidis, TJ; Liu, H; Maher, JC; Priebe, W; Savaraj, N | 1 |
Asbury, CR; Aykin-Burns, N; Coleman, MC; Cullen, JJ; Daniels, D; Du, J; Li, L; Smith, BJ; Spitz, DR | 1 |
Benyounes, H; Bruce, D; Campbell, C; Eremin, O; Evans, NT; Heys, SD; Mikecz, P; Norton, MY; Sharp, PF; Smith, FW | 1 |
al-Laith, M; Matthews, EK | 1 |
Fukatsu, H; Ikeda, M; Ishigaki, T; Isomura, T; Ito, K; Ito, S; Kato, T; Nishino, M; Ota, T; Tadokoro, M | 1 |
Hawkins, RA | 1 |
Berger, HG; Friess, H; Glatting, G; Kocher, F; Reske, SN; Stollfuss, JC | 1 |
Fujii, M; Imamura, M; Inokuma, T; Kajiyama, T; Konishi, J; Magata, Y; Ohshio, G; Tamaki, N; Torizuka, T; Yonekura, Y | 1 |
Ballmer, B; Berthold, T; Böni, R; Böni, RA; Buck, A; Burg, G; Dummer, R; Marincek, B; Steinert, H; Voellmy, D | 1 |
Beger, HG; Büchler, MW; Ebert, M; Friess, H; Langhans, J; Reske, SN; Stollfuss, J | 1 |
Fujita, T; Imamura, M; Inokuma, T; Konishi, J; Magata, Y; Ohshio, G; Tamaki, N; Torizuka, T; Yonekura, Y | 1 |
Bares, R; Büll, U; Cremerius, U; Fass, J; Hauptmann, S; Hellwig, D; Klever, P; Mittermayer, C; Schumpelick, V | 1 |
Bares, R; Buell, U; Fass, J; Hambuechen, U; Hauptmann, S; Hellwig, D; Klever, P; Mueller, B; Schumpelick, V; Zopp, L | 1 |
Bradfield, H; Gupta, N | 1 |
Barnett, CR; Flatt, PR; Gray, AM; McClenaghan, NH | 1 |
Bares, R; Büll, U; Cremerius, U; Dohmen, BM; Fass, J; Teusch, M | 1 |
Akhurst, T; Berlangieri, S; Bishop, J; Hannah, A; McKay, WJ; Scott, AM | 1 |
Chung, YS; Kawabe, J; Nakata, B; Nishihara, T; Nishimura, S; Ochi, H; Okamura, T; Sakurai, Y; Sawada, T; Sowa, M | 1 |
Askenazy, N; Kaplan, O; Knubovets, T; Kushnir, T; Navon, G | 1 |
Cobb, MH; Khoo, S | 1 |
Adam, G; Bares, R; Buell, U; Cremerius, U; Dohmen, B; Fass, J; Klever, P; Sabri, O; Schumpelick, V; Zimny, M | 1 |
Higashi, T; Honda, T; Hosotani, R; Imamura, M; Inokuma, T; Kimura, T; Konishi, J; Ohshio, G; Tamaki, N; Torizuka, T | 1 |
Beger, HG; Gansauge, F; Glatting, G; Grillenberger, KG; Hildebrandt, M; Port, M; Reske, SN | 1 |
Delvaux, A; Kadiata, MM; Malaisse, WJ; Rasschaert, J | 1 |
Adrian, TE; Li, J | 1 |
Inoue, T; Kashiwabara, A; Kawasaki, T; Muraoka, H; Ogata, E; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
Doi, K | 1 |
Bares, R; Büll, U; Fass, J; Klever, P; Schumpelick, V | 1 |
Nagamatsu, S; Steiner, DF | 1 |
Alexander, RW; Barranco, SC; Saydjari, R; Thompson, JC; Townsend, CM | 1 |
Schonbrunn, A; Sullivan, SJ | 1 |
Flatt, PR; Marks, V; Swanston-Flatt, SK; Tan, KS; Webster, JD | 1 |
de Weille, JR; Fosset, M; Lazdunski, M; Schmid-Antomarchi, H | 1 |
Bhathena, SJ; Korman, LY; Oie, HK; Recant, L; Voyles, NR | 1 |
55 other study(ies) available for deoxyglucose and Pancreatic Neoplasms
Article | Year |
---|---|
The correlation between amylin and insulin by treatment with 2-deoxy-D-glucose and/or mannose in rat insulinoma ins-1E cells.
Topics: Animals; Deoxyglucose; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Chaperone BiP; Glucose; Insulin; Insulinoma; Islet Amyloid Polypeptide; Islets of Langerhans; Mannose; Pancreatic Neoplasms; Rats | 2021 |
Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.
Topics: Acetyl Coenzyme A; Animals; Deoxyglucose; Glucose; Glycolysis; Histones; Humans; Hyperglycemia; Immunosuppression Therapy; Mice; Mice, Nude; Pancreatic Neoplasms; Polycomb Repressive Complex 1; RNA, Messenger; Streptozocin; Tumor Microenvironment | 2022 |
Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
Topics: Animals; Cell Death; Cell Line, Tumor; Deoxycytidine; Deoxyglucose; Disease Progression; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Mice; Mice, Inbred BALB C; Pancreas; Pancreatic Neoplasms; Prognosis | 2020 |
Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Bone Neoplasms; Cytochalasin B; Deoxyglucose; Depression, Chemical; Glucose; Glucose Transport Proteins, Facilitative; Humans; Insulinoma; Isomerism; Mice; Osteosarcoma; Pancreatic Neoplasms; Phloretin; Sodium-Glucose Transporter 2 Inhibitors; Tumor Cells, Cultured | 2021 |
Metabolome analysis for pancreatic cancer risk in nested case-control study: Japan Public Health Center-based prospective Study.
Topics: Adult; Aged; Asparagine; Case-Control Studies; Deoxyglucose; Female; Humans; Logistic Models; Male; Metabolome; Methionine; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Risk | 2018 |
2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Deoxyglucose; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Humans; Pancreas; Pancreatic Neoplasms; Phosphorylation; Proteomics | 2018 |
Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Deoxyglucose; Disease Progression; Drug Interactions; Female; Glycolysis; Humans; Intracellular Space; Mice; Mice, Inbred BALB C; Mitochondria; Pancreatic Neoplasms; Triazoles; Xenograft Model Antitumor Assays | 2018 |
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity.
Topics: AMP-Activated Protein Kinase Kinases; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Nucleus; Cytosol; Deoxycytidine; Deoxyglucose; Gemcitabine; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycolysis; Humans; Mutation; Pancreatic Neoplasms; Protein Kinases; Protein Transport; Signal Transduction; Sirtuin 1; Tumor Suppressor Protein p53 | 2018 |
Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Imidazoles; Nerve Growth Factor; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Pyridines; Receptor, trkA; Signal Transduction | 2013 |
Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.
Topics: Animals; Antibodies, Neoplasm; Basigin; Cell Line, Tumor; Deoxycytidine; Deoxyglucose; Drug Delivery Systems; Female; Gemcitabine; Mice; Pancreatic Neoplasms; Positron-Emission Tomography; Tumor Burden | 2014 |
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Deoxyglucose; Down-Regulation; Glucose; Glycogen Phosphorylase; Glycolysis; Humans; Isoenzymes; Pancreatic Neoplasms; Unfolded Protein Response | 2014 |
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Celecoxib; Cell Culture Techniques; Cell Growth Processes; Cell Line, Tumor; Deoxycytidine; Deoxyglucose; Doxorubicin; Energy Metabolism; Gemcitabine; Glycolysis; Humans; Hydrogen; Metformin; Mitochondria; Oxygen Consumption; Pancreatic Neoplasms; Pyrazoles; Sulfonamides | 2014 |
The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Female; Genes, Reporter; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Lactic Acid; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Pyridines; Transcription, Genetic | 2015 |
Uptake of a fluorescent L-glucose derivative 2-NBDLG into three-dimensionally accumulating insulinoma cells in a phloretin-sensitive manner.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Deoxyglucose; Fluorescence; Insulinoma; Mice; Microscopy, Confocal; Molecular Imaging; Pancreatic Neoplasms; Phloretin; Tumor Cells, Cultured | 2016 |
In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Topics: Adenosine Triphosphate; Carbon Dioxide; Cell Growth Processes; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Deoxyglucose; Dichloroacetic Acid; Glycolysis; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hypoxia-Inducible Factor 1, alpha Subunit; Pancreatic Neoplasms; RNA, Messenger | 2009 |
2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
Topics: Adenosine Triphosphate; Antimetabolites; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Deoxyglucose; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Female; Fluorescent Antibody Technique; Humans; Melanoma; Pancreatic Neoplasms; Unfolded Protein Response | 2011 |
FTS and 2-DG induce pancreatic cancer cell death and tumor shrinkage in mice.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; Deoxyglucose; Drug Synergism; Farnesol; Glycolysis; Humans; Mice; Mice, Nude; Organ Size; Pancreas; Pancreatic Neoplasms; Salicylates; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
Topics: Adenosine Triphosphate; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Hypoxia; Cell Proliferation; Deoxyglucose; Drug Synergism; Enzyme Inhibitors; Fumarates; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitochondria; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Pyruvate Dehydrogenase Complex; Pyruvates; RNA, Small Interfering; Superoxide Dismutase; Tumor Cells, Cultured | 2013 |
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Brain; Cachexia; Carbohydrate Metabolism; Deoxyglucose; Energy Metabolism; Fatty Acids, Nonesterified; Glucose; Glycolysis; Humans; Lipid Metabolism; Lipid Mobilization; Lipolysis; Male; Mice; Mice, Inbred Strains; Muscle, Skeletal; Organ Specificity; Pancreatic Neoplasms; Peptides; Weight Loss | 2002 |
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.
Topics: Adenocarcinoma; Animals; Apoptosis; Biological Transport; Blotting, Northern; Cell Division; Deoxyglucose; Flow Cytometry; Genes, Dominant; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kinetics; Mice; Mice, SCID; Pancreatic Neoplasms; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines.
Topics: Animals; Carbohydrates; Cell Division; Cell Line, Tumor; Deoxyglucose; Humans; Insulin; Insulin Secretion; Insulinoma; Pancreatic Neoplasms; Xylitol | 2003 |
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
Topics: Antimetabolites; Biomarkers, Tumor; Cell Line, Tumor; Deoxyglucose; Drug Resistance, Neoplasm; Excitatory Amino Acid Transporter 2; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Mitochondria; Pancreatic Neoplasms | 2005 |
2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxyglucose; Free Radical Scavengers; Glucose; Humans; Mice; Mice, Inbred Strains; NADP; Oxidative Stress; Pancreatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Sulfhydryl Compounds | 2008 |
Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
Topics: Adenocarcinoma; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatic Neoplasms; Tomography, Emission-Computed | 1995 |
Calcium-dependent photodynamic action of di- and tetrasulphonated aluminium phthalocyanine on normal and tumour-derived rat pancreatic exocrine cells.
Topics: Amylases; Animals; Antimycin A; Bethanechol; Calcium; Carcinoma, Acinar Cell; Deoxyglucose; Egtazic Acid; Indoles; Male; Oligomycins; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Sincalide; Stimulation, Chemical; Tumor Cells, Cultured | 1994 |
Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem.
Topics: Adenocarcinoma; Blood Glucose; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Pancreatic tumors: imaging with PET.
Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed | 1995 |
2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Topics: Adenocarcinoma; Adult; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
Topics: Adenocarcinoma; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1995 |
Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Skin Neoplasms; Tomography, Emission-Computed | 1995 |
Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
Topics: Adult; Aged; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
Topics: Adenocarcinoma; Cholangiocarcinoma; Contrast Media; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Retroperitoneal Fibrosis; ROC Curve; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1994 |
Pancreatic cancer detected by positron emission tomography with 18F-labelled deoxyglucose: method and first results.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
Topics: Colorectal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Pancreatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Hexose recognition by insulin-secreting BRIN-BD11 cells.
Topics: Animals; Cell Fusion; Cell Line; Clone Cells; Deoxyglucose; Glucokinase; Glucose; Hexokinase; Hexoses; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Mannose; Pancreatic Neoplasms; Rats | 1996 |
[Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].
Topics: Blood Glucose; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed | 1996 |
Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis.
Topics: Colon; Deoxyglucose; Enterocolitis, Pseudomembranous; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Radionuclide Imaging | 1996 |
18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Prognosis; Survival Rate; Tomography, Emission-Computed | 1997 |
Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Carcinogens; Cricetinae; Deoxyglucose; Humans; Indazoles; Magnetic Resonance Spectroscopy; Male; Mesocricetus; Neoplasm Transplantation; Pancreatic Neoplasms; Phosphorus; Protons; Rats; Rats, Sprague-Dawley; Sodium; Tumor Cells, Cultured | 1997 |
Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Colforsin; Deoxyglucose; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glucose; Insulin; Insulin Secretion; Insulinoma; JNK Mitogen-Activated Protein Kinases; Kinetics; Mannoheptulose; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Tolbutamide; Tumor Cells, Cultured | 1997 |
Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.
Topics: Adenocarcinoma; Blood Glucose; Chronic Disease; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.
Topics: Adult; Aged; Biomarkers, Tumor; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Topics: Adult; Aged; Blotting, Northern; Chromatography, High Pressure Liquid; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Pancreatitis; Polymerase Chain Reaction; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Cytotoxic action of 2-deoxy-D-glucose tetraacetate in tumoral pancreatic islet cells.
Topics: Adenoma, Islet Cell; Antineoplastic Agents; Deoxyglucose; Pancreatic Neoplasms; Tumor Cells, Cultured | 1998 |
A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts.
Topics: Animals; Biological Factors; Cell Line; Colonic Neoplasms; Culture Media, Conditioned; Cycloheximide; Cytochalasin B; Deoxyglucose; Dose-Response Relationship, Drug; Endopeptidase K; Glucose; Glucose Transporter Type 4; Humans; Insulin; Lactic Acid; Molecular Weight; Monokines; Monosaccharide Transport Proteins; Muscle Proteins; Muscles; Pancreatic Neoplasms; Rats; Somatomedins; Tumor Cells, Cultured | 1999 |
Transport of 1,5-anhydro-D-glucitol into insulinoma cells by a glucose-sensitive transport system.
Topics: Carbon Radioisotopes; Deoxyglucose; Dose-Response Relationship, Drug; Glucose; Humans; Insulinoma; Kinetics; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Temperature; Tritium; Tumor Cells, Cultured | 2000 |
[Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Topics: Adenoma, Islet Cell; Amides; Animals; Blood Glucose; Cats; Cystine; Deoxyglucose; Diabetes Mellitus; Dimethylnitrosamine; Fatty Acids, Nonesterified; Glutathione; Guinea Pigs; Insulin; Islets of Langerhans; Male; Mannoheptulose; Mice; NAD; Niacinamide; Nicotinic Acids; Pancreatic Neoplasms; Picolinic Acids; Pyrazinamide; Rabbits; Rats; Streptozocin; Tolbutamide; Uric Acid | 1975 |
PET with fluorine-18 deoxyglucose for pancreatic disease.
Topics: Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed | 1992 |
Altered glucose regulation of insulin biosynthesis in insulinoma cells: mouse beta TC3 cells secrete insulin-related peptides predominantly via a constitutive pathway.
Topics: Actins; Animals; Biological Transport; Cell Line; Deoxyglucose; Glucose; Insulin; Insulin Secretion; Insulinoma; Kinetics; Mice; Pancreatic Neoplasms; Proinsulin; RNA, Messenger | 1992 |
The effects of 2-deoxy-D-glucose and alpha-difluoromethylornithine on the growth of pancreatic cancer in vivo.
Topics: Animals; Cell Division; Cricetinae; Deoxy Sugars; Deoxyglucose; Eflornithine; Male; Mesocricetus; Pancreatic Neoplasms; Tumor Cells, Cultured | 1989 |
The processing of receptor-bound [125I-Tyr11]somatostatin by RINm5F insulinoma cells.
Topics: Adenoma, Islet Cell; Ammonium Chloride; Animals; Cells, Cultured; Deoxyglucose; Epidermal Growth Factor; Glycopeptides; Insulinoma; Iodine Radioisotopes; Lysosomes; Methylamines; Pancreatic Neoplasms; Protease Inhibitors; Rats; Receptors, Cell Surface; Receptors, Somatostatin; Somatostatin; Temperature | 1986 |
Metabolic effects and secretory properties of a radiation-induced transplantable rat insulinoma.
Topics: Adenoma, Islet Cell; Animals; Arginine; Blood Glucose; Body Weight; Deoxyglucose; Epinephrine; Feeding Behavior; Glucagon; Glyburide; Insulin; Insulinoma; Male; Neoplasms, Radiation-Induced; Pancreatic Neoplasms; Rats; Rats, Inbred Strains | 1987 |
Somatostatin activates glibenclamide-sensitive and ATP-regulated K+ channels in insulinoma cells via a G-protein.
Topics: Adenosine Triphosphate; Animals; Deoxyglucose; Glyburide; GTP-Binding Proteins; Insulinoma; Oligomycins; Pancreatic Neoplasms; Pertussis Toxin; Potassium Channels; Rats; Rubidium Radioisotopes; Somatostatin; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1988 |
Characteristics of the interaction of the glucagon receptor, cAMP, and insulin secretion in parent cells and clone 5F of a cultured rat insulinoma.
Topics: Adenoma, Islet Cell; Amino Acids; Animals; Cell Line; Clone Cells; Cyclic AMP; Deoxyglucose; Glucagon; Insulin; Insulin Secretion; Insulinoma; Pancreatic Neoplasms; Rats; Receptors, Cell Surface; Receptors, Glucagon | 1985 |